TY - JOUR
T1 - Enhanced laboratory capacity development: a boost for effective tuberculosis control in resource-limited settings
AU - Alabi, Abraham Sunday
AU - Traoré, Afsatou Ndama
AU - Loembe, Marguerite Massinga
AU - Ateba-Ngoa, Ulysse
AU - Frank, Matthias
AU - Adegnika, Ayola Akim
AU - Lell, Bertrand
AU - Mahoumbou, Jocelyn
AU - Köhler, Carsten
AU - Kremsner, Peter Gottfried
AU - Grobusch, Martin Peter
PY - 2017
Y1 - 2017
N2 - Both routine and research tuberculosis (TB) laboratory capacity urgently need to be expanded in large parts of Sub-Saharan Africa. In 2009, the Centre de Recherches Médicales de Lambaréné (CERMEL) took a strategic decision to expand its activities by building TB laboratory capacity to address research questions and to improve routine diagnostic and treatment capacity. Over the past 7 years, a standard laboratory has been developed that is contributing significantly to TB diagnosis, treatment, and control in Gabon; training has also been provided for TB research staff in Central Africa. CERMEL has a cordial relationship with the Gabon National TB Control Programme (PNLT), which has culminated in a successful Global Fund joint application. This endeavour is considered a model for similar developments needed in areas of high TB prevalence and where TB control remains poor to date
AB - Both routine and research tuberculosis (TB) laboratory capacity urgently need to be expanded in large parts of Sub-Saharan Africa. In 2009, the Centre de Recherches Médicales de Lambaréné (CERMEL) took a strategic decision to expand its activities by building TB laboratory capacity to address research questions and to improve routine diagnostic and treatment capacity. Over the past 7 years, a standard laboratory has been developed that is contributing significantly to TB diagnosis, treatment, and control in Gabon; training has also been provided for TB research staff in Central Africa. CERMEL has a cordial relationship with the Gabon National TB Control Programme (PNLT), which has culminated in a successful Global Fund joint application. This endeavour is considered a model for similar developments needed in areas of high TB prevalence and where TB control remains poor to date
U2 - https://doi.org/10.1016/j.ijid.2016.11.404
DO - https://doi.org/10.1016/j.ijid.2016.11.404
M3 - Article
C2 - 27888000
SN - 1201-9712
VL - 56
SP - 81
EP - 84
JO - International journal of infectious diseases : IJID
JF - International journal of infectious diseases : IJID
ER -